Sign In
Buy DGX
$235.84
+2.12 (+0.91%)
At Close: Aug 05, 2026
Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer
08:42am, Wednesday, 08'th Jan 2025
Quality and regulatory veteran of Getinge, BD and J&J joins the Quest Diagnostics executive team SECAUCUS, N.J. , Jan. 8, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of dia
Why Quest Diagnostics (DGX) is Poised to Beat Earnings Estimates Again
01:16pm, Friday, 03'rd Jan 2025
Quest Diagnostics (DGX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025
11:00am, Thursday, 02'nd Jan 2025
SECAUCUS, N.J. , Jan. 2, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report fourth quarter and full year 2024 f
Should You Hold Quest Diagnostics Stock in Your Portfolio Now?
08:16am, Tuesday, 31'st Dec 2024
DGX's strength in the base business and the robust adoption of Advanced Diagnostics services bode well.
New Health Coaching Service on questhealth.com Set to Boost DGX Stock
08:51am, Wednesday, 04'th Dec 2024
Quest Diagnostics introduces Health Coaching on questhealth.com, helping individuals take control of their health.
Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference
09:50am, Tuesday, 03'rd Dec 2024
SECAUCUS, N.J. , Dec. 3, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will spea
Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health
08:23am, Tuesday, 03'rd Dec 2024
New service takes the guesswork out of achieving one's health goals by empowering individuals to pair Quest lab results with personalized coaching SECAUCUS, N.J,, Dec. 3, 2024 /PRNewswire/ -- Personal
Quest Diagnostics (DGX) Up 2.7% Since Last Earnings Report: Can It Continue?
12:36pm, Thursday, 21'st Nov 2024
Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock?
Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management
01:05pm, Friday, 15'th Nov 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)-- #AxialSpondyloarthritis--Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that it has formed a nonexclusi
All You Need to Know About Quest Diagnostics (DGX) Rating Upgrade to Buy
01:00pm, Wednesday, 13'th Nov 2024
Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Quest Diagnostics Stock a Smart Addition to Your Portfolio Now?
09:20am, Wednesday, 13'th Nov 2024
DGX exhibits strength in its base business. Increasing utilization of the Advanced Diagnostics offering is another positive.
Quest Diagnostics Declares Quarterly Cash Dividend
05:57pm, Tuesday, 12'th Nov 2024
SECAUCUS, N.J. , Nov. 12, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividen
DGX vs. PNTG: Which Stock Is the Better Value Option?
12:45pm, Monday, 11'th Nov 2024
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Quest Diagnostics (DGX) and The Pennant Group, Inc. (PNTG). But which of these two companies is the bes
Here's Why You Should Retain DGX Stock in Your Portfolio Now
08:56am, Monday, 04'th Nov 2024
Investors feel optimistic about Quest Diagnostics' strength in Advanced Diagnostics. Robust base business volumes are also encouraging.
Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out?
10:16am, Friday, 25'th Oct 2024
Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
